Long-Term Efficacy and Safety Among Patients with Severe Eosinophilic Asthma Treated with Mepolizumab and Its Effect on Small Airways

Ronald Strauss, MD ● Hannah Leflein, RN, MN ● Anna Kolesar, RN, MN ●Jeffrey Hammel, MS

An article published in

The Journal of Allergy and Clinical Immunology: In Practice

December, 2023

The original publication abstract can be found here and Dr. Strauss is providing access to the full article in PDF format - Long-Term Efficacy and Safety Among Patients With Severe Eosinophilic Asthma Treated With Mepolizumab and Its Effect on Small Airways.

Next
Next

Some patients with eosinophilic asthma are ‘super-responders’ to mepolizumab